Mainstay

Mainstay Medical is an Irish medical technology company aiming to treat chronic low back pain by using their active implantable device ReActiv8

Mainstay Medical floated on Euronext Paris and the Enterprise Securities Market of the Irish Stock Exchange
Proceeds of the IPO will be used to conduct clinical trials and to obtain CE mark approval
Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner and placed 41.6% of the shares with US investors